A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy

British Journal of Cancer

Volumn 94, Issue 3, 2006, Pages 391-397

  Castano, A P ^a,b   Liu, Q ^a,b   Hamblin, M R ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Antitumour immunity; Benzoporphyrin derivative; Fluorescence imaging; Green fluorescent protein; Photodynamic therapy; Radiation induced fibrosarcoma

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ANIMAL MODEL; ARTICLE; CANCER THERAPY; IMMUNE RESPONSE; MALE; MONITORING; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR IMMUNITY; WILD TYPE;

ANIMALS; ANTIBODIES; CELL LINE, TUMOR; FIBROSARCOMA; GREEN FLUORESCENT PROTEINS; MALE; MICE; MICE, INBRED C3H; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 32544441282     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602953     Document Type: Article

References (36)

1. Brown DM, Fisher TL, Wei C, Frelinger JG, Lord EM (2001) Tumours can act as adjuvants for humoral immunity. Immunology 102: 486-497
2. Canti G, De Simone A, Korbelik M (2002) Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 1: 79-80
3. Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R (1994) Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs 5: 443-447
4. Chalfie M (1995) Green fluorescent protein. Photochem Photobiol 62: 651-656
5. Chen WR, Carubelli R, Liu H, Nordquist RE (2003) Laser immunotherapy: a novel treatment modality for metastatic tumors. Mol Biotechnol 25: 37-44
6. Chen WR, Liu H, Ritchey JW, Bartels KE, Lucroy MD, Nordquist RE (2002) Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Cancer Res 62: 4295-4299
7. Chen WR, Zhu WG, Dynlacht JR, Liu H, Nordquist RE (1999) Long-term tumor resistance induced by laser photo-immunotherapy. Int J Cancer 81: 808-812
8. Chung SW, Cohen EP, Kim TS (2004) Generation of tumor-specific cytotoxic T lymphocyte and prolongation of the survival of tumor-bearing mice using interleukin-18-secreting fibroblasts loaded with an epitope peptide. Vaccine 22: 2547-2557
9. Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3: 380-387
10. Dougherty TJ (2002) An update on photodynamic therapy applications. J Clin Laser Med Surg 20: 3-7
11. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889-905
12. Gambotto A, Dworacki G, Cicinnati V, Kenniston T, Steitz J, Tuting T, Robbins PD, DeLeo AB (2000) Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther 7: 2036-2040
13. Hoffman R (2002a) Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol 3: 546-556
14. Hoffman RM (1999a) Green fluorescent protein to visualize cancer progression and metastasis. Methods Enzymol 302: 20-31
15. Hoffman RM (1999b) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359
16. Hoffman RM (2001) Visualization of GFP-expressing tumors and metastasis in vivo. Biotechniques 30: 1016-1026
17. Hoffman RM (2002b) Whole-body fluorescence imaging with green fluorescence protein. Methods Mol Biol 183: 135-148
18. Kamiyama M, Ichikawa Y, Ishikawa T, Chishima T, Hasegawa S, Hamaguchi Y, Nagashima Y, Miyagi Y, Mitsuhashi M, Hyndman D, Hoffman RM, Ohki S, Shimada H (2002) VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice. Cancer Gene Ther 9: 197-201
19. Korbelik M (1996) Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg 14: 329-334
20. Korbelik M, Cecic I (1999) Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett 137: 91-98
21. Korbelik M, Dougherty GJ (1999) Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res 59: 1941-1946
22. Korbelik M, Sun J, Posakony JJ (2001) Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Photochem Photobiol 73: 403-409
23. Nelson DJ, Mukherjee S, Bundell C, Fisher S, van Hagen D, Robinson B (2001) Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL. J Immunol 166: 5557-5566
24. Re F, Srinivasan R, Igarashi T, Marincola F, Childs R (2004) Green fluorescent protein expression in dendritic cells enhances their immunogenicity and elicits specific cytotoxic T-cell responses in humans. Exp Hematol 32: 210-217
25. Rosenzweig M, Connole M, Glickman R, Yue SP, Noren B, DeMaria M, Johnson RP (2001) Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 97: 1951-1959
26. Sacchetti A, Ciccocioppo R, Alberti S (2000) The molecular determinants of the efficiency of green fluorescent protein mutants. Histol Histopathol 15: 101-107
27. Smith RA, Cokkinides V, Eyre HJ, Society AC (2004) American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 54: 41-52
28. Spiotto MT, Reth MA, Schreiber H (2003) Genetic changes occurring in established tumors rapidly stimulate new antibody responses. Proc Natl Acad Sci USA 100: 5425-5430
29. Stripecke R, Carmen Villacres M, Skelton D, Satake N, Halene S, Kohn D (1999) Immune response to green fluorescent protein: implications for gene therapy. Gene Therapy 6: 1305-1312
30. Suzuki M, Shinkai M, Honda H, Kobayashi T (2003) Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 13: 129-135
31. Twentyman PR, Brown JM, Gray JW, Franko AJ, Scoles MA, Kallman RF (1980) A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 64: 595-604
32. van Broekhoven CL, Parish CR, Demangel C, Britton WJ, Altin JG (2004) Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res 64: 4357-4365
33. Wang JW, Yang M, Wang X, Sun FX, Li XM, Yagi S, Hoffman RM (2003) Antimetastatic efficacy of oral 5-FU imaged by green fluorescent protein in real time. Anticancer Res 23: 1-6
34. Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP (1995a) Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J Immunol 154: 4685-4692
35. Wang M, Chen PW, Bronte V, Rosenberg SA, Restifo NP (1995b) Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen. J Immunother Emphasis Tumor Immunol 18: 139-146
36. Yamamoto N, Yang M, Jiang P, Xu M, Tsuchiya H, Tomita K, Moossa AR, Hoffman RM (2003) Real-time imaging of individual fluorescent-protein color-coded metastatic colonies in vivo. Clin Exp Metastasis 20: 633-638